Publication | Closed Access

A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery

Drug TargetingEngineeringImmunoengineeringImmunologyTargeted Drug DeliveryBioconjugationDrug Delivery SystemsAntibody EngineeringProtein EngineeringSite-specific DeliverySite-specific ConjugationMedicineAntibody-avidin Fusion ProteinBiomolecular Engineering